Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2014, 15(7), 12422-12441; doi:10.3390/ijms150712422
Article

DADS Suppresses Human Esophageal Xenograft Tumors through RAF/MEK/ERK and Mitochondria-Dependent Pathways

1,†
, 2,†
, 1
, 2
, 2
, 3
, 4
, 2
, 1
, 5
, 1
, 6
, 1
 and 1,*
Received: 5 May 2014; in revised form: 22 June 2014 / Accepted: 7 July 2014 / Published: 14 July 2014
(This article belongs to the Special Issue Molecular Science for Drug Development and Biomedicine)
View Full-Text   |   Download PDF [3145 KB, uploaded 14 July 2014]   |   Browse Figures
Abstract: Diallyl disulfide (DADS) is a natural organosulfur compound isolated from garlic. DADS has various biological properties, including anticancer, antiangiogenic, and antioxidant effects. However, the anticancer mechanisms of DADS in human esophageal carcinoma have not been elucidated, especially in vivo. In this study, MTT assay showed that DADS significantly reduced cell viability in human esophageal carcinoma ECA109 cells, but was relatively less toxic in normal liver cells. The pro–apoptotic effect of DADS on ECA109 cells was detected by Annexin V-FITC/propidium iodide (PI) staining. Flow cytometry analysis showed that DADS promoted apoptosis in a dose-dependent manner and the apoptosis rate could be decreased by caspase-3 inhibitor Ac-DEVD-CHO. Xenograft study in nude mice showed that DADS treatment inhibited the growth of ECA109 tumor in both 20 and 40 mg/kg DADS groups without obvious side effects. DADS inhibited ECA109 tumor proliferation by down-regulating proliferation cell nuclear antigen (PCNA). DADS induced apoptosis by activating a mitochondria-dependent pathway with the executor of caspase-3, increasing p53 level and Bax/Bcl-2 ratio, and downregulating the RAF/MEK/ERK pathway in ECA109 xenograft tumosr. Based on studies in cell culture and animal models, the findings here indicate that DADS is an effective and safe anti-cancer agent for esophageal carcinoma.
Keywords: esophageal carcinoma; DADS; apoptosis; animal model esophageal carcinoma; DADS; apoptosis; animal model
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Yin, X.; Zhang, J.; Li, X.; Liu, D.; Feng, C.; Liang, R.; Zhuang, K.; Cai, C.; Xue, X.; Jing, F.; Wang, X.; Wang, J.; Liu, X.; Ma, H. DADS Suppresses Human Esophageal Xenograft Tumors through RAF/MEK/ERK and Mitochondria-Dependent Pathways. Int. J. Mol. Sci. 2014, 15, 12422-12441.

AMA Style

Yin X, Zhang J, Li X, Liu D, Feng C, Liang R, Zhuang K, Cai C, Xue X, Jing F, Wang X, Wang J, Liu X, Ma H. DADS Suppresses Human Esophageal Xenograft Tumors through RAF/MEK/ERK and Mitochondria-Dependent Pathways. International Journal of Molecular Sciences. 2014; 15(7):12422-12441.

Chicago/Turabian Style

Yin, Xiaoran; Zhang, Jun; Li, Xiaoning; Liu, Dong; Feng, Cheng; Liang, Rongrui; Zhuang, Kun; Cai, Chenlei; Xue, Xinghuan; Jing, Fuchun; Wang, Xijing; Wang, Jun; Liu, Xinlian; Ma, Hongbing. 2014. "DADS Suppresses Human Esophageal Xenograft Tumors through RAF/MEK/ERK and Mitochondria-Dependent Pathways." Int. J. Mol. Sci. 15, no. 7: 12422-12441.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert